Showing all 14 results
Artesunate & Sulphadoxine-Pyrimethamine Tablets
FreeProduct Composition & Kit Configuration
We supply this product in standardized, age-titrated Fixed-Dose Combination (FDC) Blister Strips, commonly containing a 3-day course of Artesunate tablets alongside a single-dose treatment of Sulfadoxine-Pyrimethamine.
Component Tablet Type Active Ingredient Mix Standard Strengths (per Tablet) Primary Clinical Function Artesunate Tablet Artesunate 50 mg / 100 mg / 200 mg The Fast Cleaver: Clears parasite biomass over 3 consecutive days. Sulfadoxine-Pyrimethamine Tablet Sulfadoxine + Pyrimethamine 500 mg + 25 mg The Extended Shield: Single-dose companion to prevent recrudescence. Clofazimine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Micronized Lipid-Matrix Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive phenazine dye.
Active Ingredient Strength Primary Clinical Function Clofazimine USP/Ph.Eur. 50 mg The Standard MDT Maintenance Unit: The globally standardized daily dose utilized in the WHO Multi-Drug Therapy (MDT) regimen for Multibacillary Leprosy. Clofazimine USP/Ph.Eur. 100 mg The MDR-TB & Acute ENL Macrodose: The heavy therapeutic payload utilized for the aggressive suppression of acute ENL reactions or as a core component of the standardized short-course MDR-TB regimen. Excipients Microcrystalline Cellulose / Propylene Glycol / Gelatin / Sodium Lauryl Sulfate / Magnesium Stearate / Heavy Opaque Polymeric Film Diluent / Lipid-Solvent Matrix / Binder / Surfactant / Lubricant / Protective Light Shield (Engineered specifically utilizing Advanced API Micronization & Solid-Lipid Tableting. Because Clofazimine is practically insoluble in water, the API is micro-milled and suspended in a specialized surfactant matrix to ensure it absorbs perfectly in the gut without requiring a soft-gelatin encapsulation process) *Pack Sizes: 10×10 Blisters or Bottles of 100 (Optimized specifically for strict, continuous, multi-year infectious disease dispensing regimens).
Diloxanide Furoate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Luminal-Dispersion Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical stability of the anti-parasitic ester.
Active Ingredient Strength Primary Clinical Function Diloxanide Furoate USP/Ph.Eur. 500 mg The Global Anti-Parasitic Standard: The definitive therapeutic macrodose utilized globally for the total luminal eradication of amoebic cysts in asymptomatic carriers and post-dysentery patients. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Colloidal Silicon Dioxide / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Glidant / Film-Coating (Engineered specifically utilizing advanced high-shear granulation and elite superdisintegrants to ensure the massive 500mg tablet shatters and disperses uniformly across the intestinal lining, maximizing physical contact with the embedded cysts) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, 10-day acute parasitology eradication regimens).
Dolutegravir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Polymorphically Stabilized Microdose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the Dolutegravir Sodium salt.
Active Ingredient Strength Primary Clinical Function Dolutegravir (as Sodium) USP/Ph.Eur. 50 mg The Global INSTI Anchor: The definitive therapeutic payload required to force immediate, systemic viral suppression and maintain an undetectable viral load. Excipients D-Mannitol / Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone K-30 / Sodium Stearyl Fumarate / Premium Polymeric Film Diluent / Binder / Superdisintegrant / Glidant / Heavy Film-Coating (Engineered specifically utilizing strict low-moisture granulation to prevent the active Dolutegravir Sodium from undergoing polymorphic shifts during compression, guaranteeing absolute pharmacokinetic bioequivalence) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).
Efavirenz ,Emtricitabine & Tenofovir Disoproxil Fumarate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Mega-Dose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles to ensure the absolute chemical survival of the moisture-sensitive Tenofovir and light-sensitive Efavirenz.
Active Ingredient Strength Primary Clinical Function Efavirenz USP/Ph.Eur. 600 mg The NNRTI Anchor: The massive, highly lipophilic non-nucleoside payload required to force immediate, systemic viral suppression. Emtricitabine (FTC) USP/Ph.Eur. 200 mg The Cytidine Analogue: Provides profound, long-acting intracellular viral suppression to reinforce the backbone. Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur. 300 mg The Nucleotide Backbone: The heavy-hitting chain terminator required to completely halt viral DNA elongation. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Hydroxypropyl Cellulose / Sodium Lauryl Sulfate / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Surfactant / Heavy Film-Coating (Engineered utilizing High-Compression Bi-Layer Technology to fuse 1,100mg of active API into a single, aerodynamically shaped tablet that remains easy for patients to swallow, heavily coated to lock out destructive tropical humidity) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).
Efavirenz Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Macrodose Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the highly lipophilic active ingredient.
Active Ingredient Strength Primary Clinical Function Efavirenz USP/Ph.Eur. 600 mg The Global NNRTI Macrodose: The massive therapeutic payload required to force immediate, systemic viral suppression when combined with a dual-NRTI backbone. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Sodium Lauryl Sulfate / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Surfactant / Binder / Heavy Film-Coating (Engineered specifically utilizing powerful surfactants like Sodium Lauryl Sulfate to drastically increase the solubility of the notoriously lipophilic Efavirenz molecule, ensuring rapid and complete gastrointestinal absorption) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 or 10×10 Alu-Alu Blisters (Optimized specifically for massive NGO distribution and chronic daily dispensing regimens).
Emtricitabine & Tenofovir Disoproxil Fumarate Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Hydrolytically Shielded Macrodose FDC Tablet, packed exclusively in highly secure, moisture-resistant heavy-gauge HDPE bottles or Alu-Alu blister strips to ensure the absolute chemical survival of the moisture-sensitive Tenofovir.
Active Ingredient Strength Primary Clinical Function Emtricitabine (FTC) USP/Ph.Eur. 200 mg The Cytidine Analogue: Provides profound, long-acting intracellular viral suppression with an exceptionally favorable safety profile. Tenofovir Disoproxil Fumarate (TDF) USP/Ph.Eur. 300 mg
(Eq. to 245 mg Tenofovir Disoproxil)The Nucleotide Backbone: The heavy-hitting reverse transcriptase inhibitor required to anchor the ARV regimen and prevent viral breakthrough. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Lactose Monohydrate / Magnesium Stearate / Premium Polymeric Film (Opadry) Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically utilizing dry-granulation and heavy film-coating to protect the API from atmospheric moisture, ensuring the massive 500mg active payload remains structurally intact and easily swallowable) *Pack Sizes: Heavy-Gauge HDPE Bottles of 30 (Optimized specifically for massive NGO distribution and strict 30-day chronic daily dispensing regimens).
Fluconazole Capsules
FreeFluconazole capsules (commonly known by the brand name Diflucan (pfizermedical.com)) contain the active antifungal ingredient fluoxetine hydrochloride along with a powder fill of inactive excipients and a hard gelatin shell.
Furazolidone Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Light-Shielded Tablet, packed exclusively in highly secure, opaque Alu-PVC or heavy-gauge Alu-Alu blister strips to ensure the absolute chemical survival of the intensely photolabile (light-sensitive) nitrofuran molecule.
Active Ingredient Strength Primary Clinical Function Furazolidone USP/Ph.Eur. 100 mg Global Outbreak & Dysentery Standard: The definitive therapeutic unit utilized for rapid, massive-dose eradication of intestinal protozoa and severe bacterial enteritis. Excipients Microcrystalline Cellulose / Sodium Starch Glycolate / Povidone / Magnesium Stearate / Premium Opacifying Film-Coat Diluent / Superdisintegrant / Binder / Lubricant / UV-Barrier Film (Engineered specifically using heavy Titanium Dioxide film-coating to block ultraviolet light, preventing the yellow Furazolidone powder from oxidizing and degrading into a useless brown paste before ingestion) *Pack Sizes: 10×10 Blisters (Optimized specifically for rapid NGO deployment and short-course 5-to-7 day dysentery eradication protocols).
Ganciclovir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient and protect healthcare handlers from cytotoxic exposure.
Active Ingredient Strength Primary Clinical Function Ganciclovir USP/Ph.Eur. 250 mg Renal Titration Standard: Base therapeutic unit utilized for strict, calculated dose reductions in transplant patients suffering from severe renal impairment (low creatinine clearance). Ganciclovir USP/Ph.Eur. 500 mg Global Maintenance Standard: High-efficacy adult maintenance dose utilized for daily, long-term suppression of CMV retinitis to prevent viral relapse. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant / Heavy Film-Coating (Engineered specifically to lock the highly mutagenic and carcinogenic API safely inside the tablet, completely preventing caregiver and pharmacist exposure to toxic airborne dust) *Pack Sizes: 10×10 Alu-Alu Blisters or Bottles of 84 (Optimized specifically for strict, high-volume chronic infectious disease dispensing regimens).
Lamivudine & Zidovudine tablets
FreeProduct Composition & Strength
We supply this product in the internationally standardized Fixed-Dose Combination (FDC) required for therapeutic compliance.
Active Ingredient Strength (per Tablet) Primary Clinical Function Lamivudine (3TC) IP/BP/USP 150 mg The Chain Terminator: High potency, low toxicity. Zidovudine (AZT) IP/BP/USP 300 mg The Foundation: Proven efficacy in preventing replication. Excipients Pharma Grade The Matrix: Ensures stability of the sensitive FDC. Ledipasvir & Sofosbuvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dual-Active FDC Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles with specialized desiccants to ensure the absolute chemical survival of the complex antiviral APIs.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg The NS5A Anchor: Potent inhibitor of viral assembly and secretion; highly effective against specific HCV genotypes. Sofosbuvir USP/Ph.Eur. 400 mg The NS5B Backbone: The globally recognized foundational DAA that forces viral RNA chain termination across multiple genotypes. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Binder / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically to solve the massive solubility differences between the highly soluble Sofosbuvir and the poorly soluble Ledipasvir, guaranteeing synchronized gastric release and peak systemic absorption) *Pack Sizes: Bottles of 28 (Optimized specifically for the strict 4-week dispensing intervals required for 8, 12, or 24-week curative regimens).
Ledipasvir Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Solid-Dispersion Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips or heavy-gauge HDPE bottles to ensure the absolute chemical survival of the complex antiviral API.
Active Ingredient Strength Primary Clinical Function Ledipasvir USP/Ph.Eur. 90 mg Global Hepatology Standard: The definitive daily dose required to maintain constant, paralyzing pressure on the NS5A viral protein across the entire 12-to-24 week curative cycle. Excipients Copovidone / Lactose Monohydrate / Microcrystalline Cellulose / Croscarmellose Sodium / Magnesium Stearate / Premium Opadry Film Solubility Enhancer / Diluent / Superdisintegrant / Lubricant / Film-Coating (Engineered specifically utilizing Amorphous Solid Dispersion techniques with Copovidone to force the highly insoluble Ledipasvir to dissolve instantly in gastric fluid, guaranteeing maximum systemic bioavailability) *Pack Sizes: Bottles of 28 or 10×10 Blisters (Optimized specifically for strict 4-week dispensing intervals to match custom DAA combination regimens).
Rifampicin & Isoniazid Tablets
FreeProduct Composition & Strength (RH 300/150)
We supply this product in standardized Fixed-Dose Combinations (FDCs) as per international pharmacopoeial standards.
Active Ingredient Strength (per Tablet) Primary Clinical Function Rifampicin IP/BP/USP 300 mg The RNA Blocker: Sterilizing agent against TB bacilli. Isoniazid IP/BP/USP 150 mg The Wall Breaker: Potent bactericidal agent. Excipients Pharma Grade The Matrix: Ensures stability of the FDC.
